Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA
about
Identification of Ezetimibe and Pranlukast as Pharmacological Chaperones for the Treatment of the Rare Disease Mucopolysaccharidosis Type IVA
description
2019 nî lūn-bûn
@nan
2019年の論文
@ja
2019年学术文章
@wuu
2019年学术文章
@zh
2019年学术文章
@zh-cn
2019年学术文章
@zh-hans
2019年学术文章
@zh-my
2019年学术文章
@zh-sg
2019年學術文章
@yue
2019年學術文章
@zh-hant
name
Identification of Ezetimibe an ...... Mucopolysaccharidosis Type IVA
@en
type
label
Identification of Ezetimibe an ...... Mucopolysaccharidosis Type IVA
@en
prefLabel
Identification of Ezetimibe an ...... Mucopolysaccharidosis Type IVA
@en
P2093
P50
P1476
Identification of Ezetimibe an ...... Mucopolysaccharidosis Type IVA
@en
P2093
Andrés Felipe Rojas-Rodriguez
Esteban Guzman
Luisa Natalia Pimentel-Vera
María Alejandra Puentes-Tellez
Oscar A Hidalgo
Rafael Garzón
Sergio Olarte-Avellaneda
P304
P356
10.1021/ACS.JMEDCHEM.9B00428
P577
2019-06-25T00:00:00Z